A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports. The findings support further development of the drug candidate for treating and preventing current coronavirus infections and potential future epidemic outbreaks.